Fundraising FoxSeurat Therapeutics
Chicago, US · Founded 2016 · Delaware corporation
Find your way into Seurat Therapeutics
Sign up to see every warm intro you have to Seurat Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Seurat Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Seurat Therapeutics is a biopharmaceutical company focused on discovering and developing novel neurotherapeutics, with research centered on immune signaling in brain health. Its work addresses conditions such as migraine and other neurological diseases.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$773.5K disclosed across 1 round · 2018
▶$773.5KraisedFeb 2018 · 5 investors · BiotechnologyRule 506(b)
- Yuan ZhangExecutive Officer, Director
- Martin SandersExecutive Officer, Director
- Sharon LewExecutive Officer
- Richard KraigExecutive Officer, Director
- Offering amount
- $773.5K
- Amount sold
- $773.5K
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $509.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Seurat Therapeutics do?
- Seurat Therapeutics is a biopharmaceutical company focused on discovering and developing novel neurotherapeutics, with research centered on immune signaling in brain health. Its work addresses conditions such as migraine and other neurological diseases.
- How much funding has Seurat Therapeutics raised?
- Seurat Therapeutics has disclosed $773.5K raised across 1 round.
- Where is Seurat Therapeutics headquartered?
- Seurat Therapeutics is headquartered in Chicago, US.